25 XP   0   0   10

Beijing Beilu Pharmaceutical
Buy, Hold or Sell?

Let's analyse Beilu together

PenkeI guess you are interested in Beijing Beilu Pharmaceutical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beijing Beilu Pharmaceutical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beijing Beilu Pharmaceutical

I send you an email if I find something interesting about Beijing Beilu Pharmaceutical.

Quick analysis of Beilu (30 sec.)










What can you expect buying and holding a share of Beilu? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥3.83
Expected worth in 1 year
¥3.66
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
¥0.06
Return On Investment
1.2%

For what price can you sell your share?

Current Price per Share
¥4.94
Expected price per share
¥3.58 - ¥6.54
How sure are you?
50%

1. Valuation of Beilu (5 min.)




Live pricePrice per Share (EOD)

¥4.94

Intrinsic Value Per Share

¥-5.32 - ¥0.25

Total Value Per Share

¥-1.49 - ¥4.08

2. Growth of Beilu (5 min.)




Is Beilu growing?

Current yearPrevious yearGrowGrow %
How rich?$260.3m$285.2m-$21.5m-8.2%

How much money is Beilu making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m$1.7m-$3.1m-220.0%
Net Profit Margin-4.8%6.6%--

How much money comes from the company's main activities?

3. Financial Health of Beilu (5 min.)




What can you expect buying and holding a share of Beilu? (5 min.)

Welcome investor! Beilu's management wants to use your money to grow the business. In return you get a share of Beilu.

What can you expect buying and holding a share of Beilu?

First you should know what it really means to hold a share of Beilu. And how you can make/lose money.

Speculation

The Price per Share of Beilu is ¥4.94. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Beilu.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Beilu, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.83. Based on the TTM, the Book Value Change Per Share is ¥-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Beilu.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.1%0.010.2%0.010.2%
Usd Book Value Change Per Share0.00-0.1%-0.01-0.1%0.000.0%0.010.2%0.010.2%
Usd Dividend Per Share0.000.0%0.010.2%0.000.1%0.010.1%0.000.1%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.0%0.020.3%0.010.3%
Usd Price Per Share0.95-0.93-1.10-1.19-1.87-
Price to Earnings Ratio-110.94--235.91-275.34-27.91-52.01-
Price-to-Total Gains Ratio-605.08--487.32-502.66-55.56-95.22-
Price to Book Ratio1.80-1.74-1.90-2.51-6.78-
Price-to-Total Gains Ratio-605.08--487.32-502.66-55.56-95.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.682214
Number of shares1465
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share0.000.02
Gains per Quarter (1465 shares)2.8822.39
Gains per Year (1465 shares)11.5089.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
147-352325880
293-701464116170
3140-1052695173260
4186-14038127231350
5233-17550159289440
6279-21062191347530
7326-24574222404620
8373-28086254462710
9419-31698286520800
10466-351110318578890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%7.05.00.058.3%15.05.00.075.0%33.05.02.082.5%50.05.02.087.7%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%14.06.00.070.0%31.09.00.077.5%45.012.00.078.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.02.090.0%36.00.04.090.0%47.00.010.082.5%
Total Gains per Share1.03.00.025.0%8.04.00.066.7%16.04.00.080.0%34.06.00.085.0%51.06.00.089.5%

Fundamentals of Beilu

About Beijing Beilu Pharmaceutical

Beijing Beilu Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company's products include contrast agents, central nervous system products, and oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. also produces precision medicine. The company was founded in 1992 and is based in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-16 11:27:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Beijing Beilu Pharmaceutical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Beilu earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -3.6% means that ¥-0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beijing Beilu Pharmaceutical:

  • The MRQ is -3.6%. The company is making a loss. -1
  • The TTM is -4.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-4.8%+1.2%
TTM-4.8%YOY6.6%-11.4%
TTM-4.8%5Y16.1%-20.9%
5Y16.1%10Y17.6%-1.6%
1.1.2. Return on Assets

Shows how efficient Beilu is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.3% Return on Assets means that Beilu generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beijing Beilu Pharmaceutical:

  • The MRQ is -0.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-0.4%+0.1%
TTM-0.4%YOY0.4%-0.8%
TTM-0.4%5Y1.9%-2.3%
5Y1.9%10Y2.2%-0.4%
1.1.3. Return on Equity

Shows how efficient Beilu is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.4% Return on Equity means Beilu generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beijing Beilu Pharmaceutical:

  • The MRQ is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.6%+0.2%
TTM-0.6%YOY0.7%-1.3%
TTM-0.6%5Y2.3%-2.9%
5Y2.3%10Y2.7%-0.4%

1.2. Operating Efficiency of Beijing Beilu Pharmaceutical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Beilu is operating .

  • Measures how much profit Beilu makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beijing Beilu Pharmaceutical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.5%+0.5%
TTM-0.5%YOY3.7%-4.2%
TTM-0.5%5Y11.9%-12.5%
5Y11.9%10Y6.7%+5.3%
1.2.2. Operating Ratio

Measures how efficient Beilu is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.53 means that the operating costs are ¥1.53 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Beijing Beilu Pharmaceutical:

  • The MRQ is 1.531. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.521. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.531TTM1.521+0.010
TTM1.521YOY1.373+0.148
TTM1.5215Y1.260+0.261
5Y1.26010Y0.782+0.478

1.3. Liquidity of Beijing Beilu Pharmaceutical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Beilu is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.76 means the company has ¥3.76 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Beijing Beilu Pharmaceutical:

  • The MRQ is 3.758. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.053. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.758TTM4.053-0.295
TTM4.053YOY4.315-0.262
TTM4.0535Y4.582-0.530
5Y4.58210Y2.486+2.097
1.3.2. Quick Ratio

Measures if Beilu is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.51 means the company can pay off ¥0.51 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beijing Beilu Pharmaceutical:

  • The MRQ is 0.511. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.630. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.511TTM0.630-0.118
TTM0.630YOY1.331-0.701
TTM0.6305Y1.330-0.700
5Y1.33010Y2.311-0.981

1.4. Solvency of Beijing Beilu Pharmaceutical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Beilu assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Beilu to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.34 means that Beilu assets are financed with 34.3% credit (debt) and the remaining percentage (100% - 34.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beijing Beilu Pharmaceutical:

  • The MRQ is 0.343. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.330. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.343TTM0.330+0.013
TTM0.330YOY0.291+0.039
TTM0.3305Y0.236+0.094
5Y0.23610Y0.175+0.061
1.4.2. Debt to Equity Ratio

Measures if Beilu is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 56.5% means that company has ¥0.57 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beijing Beilu Pharmaceutical:

  • The MRQ is 0.565. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.533. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.565TTM0.533+0.032
TTM0.533YOY0.456+0.077
TTM0.5335Y0.360+0.173
5Y0.36010Y0.252+0.108

2. Market Valuation of Beijing Beilu Pharmaceutical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Beilu generates.

  • Above 15 is considered overpriced but always compare Beilu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -110.94 means the investor is paying ¥-110.94 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beijing Beilu Pharmaceutical:

  • The EOD is -79.315. Based on the earnings, the company is expensive. -2
  • The MRQ is -110.945. Based on the earnings, the company is expensive. -2
  • The TTM is -235.910. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-79.315MRQ-110.945+31.630
MRQ-110.945TTM-235.910+124.966
TTM-235.910YOY275.336-511.247
TTM-235.9105Y27.912-263.822
5Y27.91210Y52.008-24.096
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beijing Beilu Pharmaceutical:

  • The EOD is -15.647. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -21.887. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 50.328. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-15.647MRQ-21.887+6.240
MRQ-21.887TTM50.328-72.215
TTM50.328YOY-266.927+317.255
TTM50.3285Y27.232+23.096
5Y27.23210Y-13.797+41.030
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Beilu is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Beijing Beilu Pharmaceutical:

  • The EOD is 1.289. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.803. Based on the equity, the company is underpriced. +1
  • The TTM is 1.743. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.289MRQ1.803-0.514
MRQ1.803TTM1.743+0.060
TTM1.743YOY1.901-0.158
TTM1.7435Y2.508-0.765
5Y2.50810Y6.782-4.274
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beijing Beilu Pharmaceutical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.018-0.043+138%-0.008-56%0.071-126%0.068-127%
Book Value Per Share--3.8333.881-1%4.193-9%3.567+7%2.663+44%
Current Ratio--3.7584.053-7%4.315-13%4.582-18%2.486+51%
Debt To Asset Ratio--0.3430.330+4%0.291+18%0.236+46%0.175+96%
Debt To Equity Ratio--0.5650.533+6%0.456+24%0.360+57%0.252+124%
Dividend Per Share--0.0070.058-88%0.025-73%0.039-83%0.034-80%
Eps---0.016-0.008-46%0.026-161%0.071-122%0.061-125%
Free Cash Flow Per Share---0.079-0.020-75%-0.024-69%0.009-954%0.034-329%
Free Cash Flow To Equity Per Share---0.079-0.145+84%-0.091+15%0.023-443%0.054-246%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Intrinsic Value_10Y_max--0.251--------
Intrinsic Value_10Y_min---5.319--------
Intrinsic Value_1Y_max--0.122--------
Intrinsic Value_1Y_min---0.123--------
Intrinsic Value_3Y_max--0.292--------
Intrinsic Value_3Y_min---0.726--------
Intrinsic Value_5Y_max--0.373--------
Intrinsic Value_5Y_min---1.717--------
Market Cap2430158939.520-40%3399270905.2803326745608.320+2%3935593819.810-14%4232522672.629-20%6649942978.905-49%
Net Profit Margin---0.036-0.048+33%0.066-155%0.161-123%0.176-121%
Operating Margin----0.0050%0.037-100%0.119-100%0.067-100%
Operating Ratio--1.5311.521+1%1.373+12%1.260+22%0.782+96%
Pb Ratio1.289-40%1.8031.743+3%1.901-5%2.508-28%6.782-73%
Pe Ratio-79.315+29%-110.945-235.910+113%275.336-140%27.912-497%52.008-313%
Price Per Share4.940-40%6.9106.763+2%7.990-14%8.584-20%13.508-49%
Price To Free Cash Flow Ratio-15.647+29%-21.88750.328-143%-266.927+1120%27.232-180%-13.797-37%
Price To Total Gains Ratio-432.574+29%-605.078-487.315-19%502.659-220%55.562-1189%95.224-735%
Quick Ratio--0.5110.630-19%1.331-62%1.330-62%2.311-78%
Return On Assets---0.003-0.004+40%0.004-162%0.019-114%0.022-112%
Return On Equity---0.004-0.006+36%0.007-165%0.023-119%0.027-116%
Total Gains Per Share---0.0110.014-180%0.017-168%0.111-110%0.102-111%
Usd Book Value--260383902.532263671587.370-1%285218933.937-9%242838123.985+7%181173523.853+44%
Usd Book Value Change Per Share---0.003-0.006+138%-0.001-56%0.010-126%0.009-127%
Usd Book Value Per Share--0.5290.536-1%0.579-9%0.493+7%0.368+44%
Usd Dividend Per Share--0.0010.008-88%0.003-73%0.005-83%0.005-80%
Usd Eps---0.002-0.001-46%0.004-161%0.010-122%0.008-125%
Usd Free Cash Flow---5362196.185-1326142.793-75%-1642819.244-69%629320.551-952%2221793.766-341%
Usd Free Cash Flow Per Share---0.011-0.003-75%-0.003-69%0.001-954%0.005-329%
Usd Free Cash Flow To Equity Per Share---0.011-0.020+84%-0.013+15%0.003-443%0.007-246%
Usd Market Cap335604949.548-40%469439312.019459423568.509+2%543505506.516-14%584511381.090-20%918357125.387-49%
Usd Price Per Share0.682-40%0.9540.934+2%1.103-14%1.185-20%1.865-49%
Usd Profit---1057822.715-1453039.708+37%1742947.838-161%4672661.067-123%4092218.717-126%
Usd Revenue--29247998.17829636008.309-1%24870901.114+18%27965742.187+5%22661255.500+29%
Usd Total Gains Per Share---0.0020.002-180%0.002-168%0.015-110%0.014-111%
 EOD+3 -5MRQTTM+12 -22YOY+6 -295Y+8 -2710Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Beijing Beilu Pharmaceutical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-79.315
Price to Book Ratio (EOD)Between0-11.289
Net Profit Margin (MRQ)Greater than0-0.036
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.511
Current Ratio (MRQ)Greater than13.758
Debt to Asset Ratio (MRQ)Less than10.343
Debt to Equity Ratio (MRQ)Less than10.565
Return on Equity (MRQ)Greater than0.15-0.004
Return on Assets (MRQ)Greater than0.05-0.003
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Beijing Beilu Pharmaceutical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.927
Ma 20Greater thanMa 504.742
Ma 50Greater thanMa 1004.895
Ma 100Greater thanMa 2005.749
OpenGreater thanClose4.890
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  1,99412,50514,499-11,9002,5994,3216,919-17,918-10,998



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,871,051
Total Liabilities985,578
Total Stockholder Equity1,744,333
 As reported
Total Liabilities 985,578
Total Stockholder Equity+ 1,744,333
Total Assets = 2,871,051

Assets

Total Assets2,871,051
Total Current Assets1,229,625
Long-term Assets1,641,427
Total Current Assets
Cash And Cash Equivalents 760,441
Short-term Investments 20,000
Net Receivables 147,379
Inventory 250,330
Other Current Assets 6,866
Total Current Assets  (as reported)1,229,625
Total Current Assets  (calculated)1,185,015
+/- 44,610
Long-term Assets
Property Plant Equipment 862,680
Goodwill 31,822
Intangible Assets 115,301
Long-term Assets Other 4,708
Long-term Assets  (as reported)1,641,427
Long-term Assets  (calculated)1,014,511
+/- 626,916

Liabilities & Shareholders' Equity

Total Current Liabilities327,245
Long-term Liabilities658,332
Total Stockholder Equity1,744,333
Total Current Liabilities
Short Long Term Debt 160,177
Accounts payable 105,130
Other Current Liabilities 111
Total Current Liabilities  (as reported)327,245
Total Current Liabilities  (calculated)265,418
+/- 61,827
Long-term Liabilities
Long term Debt 584,321
Capital Lease Obligations Min Short Term Debt7,896
Long-term Liabilities  (as reported)658,332
Long-term Liabilities  (calculated)592,217
+/- 66,116
Total Stockholder Equity
Retained Earnings 838,721
Total Stockholder Equity (as reported)1,744,333
Total Stockholder Equity (calculated)838,721
+/- 905,612
Other
Capital Stock491,935
Common Stock Shares Outstanding 491,935
Net Invested Capital 2,488,831
Net Working Capital 902,379
Property Plant and Equipment Gross 862,680



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302008-12-312007-12-312006-12-31
> Total Assets 
126,313
142,416
159,749
168,163
183,635
451,309
471,580
472,229
468,072
475,113
486,830
481,749
493,634
524,656
532,282
521,892
540,334
583,597
594,511
581,331
601,779
620,542
654,517
650,791
674,804
907,005
932,427
953,113
992,822
1,050,020
1,088,850
1,063,560
1,027,750
956,093
1,000,809
1,048,061
1,096,478
1,140,885
1,169,886
1,213,661
1,261,081
1,288,719
1,328,461
1,334,145
1,389,167
1,623,818
1,932,110
2,052,933
2,207,170
2,847,574
2,869,515
2,907,496
2,906,673
2,902,883
2,967,839
2,962,626
2,815,910
2,815,514
2,877,715
2,833,821
2,871,051
2,871,0512,833,8212,877,7152,815,5142,815,9102,962,6262,967,8392,902,8832,906,6732,907,4962,869,5152,847,5742,207,1702,052,9331,932,1101,623,8181,389,1671,334,1451,328,4611,288,7191,261,0811,213,6611,169,8861,140,8851,096,4781,048,0611,000,809956,0931,027,7501,063,5601,088,8501,050,020992,822953,113932,427907,005674,804650,791654,517620,542601,779581,331594,511583,597540,334521,892532,282524,656493,634481,749486,830475,113468,072472,229471,580451,309183,635168,163159,749142,416126,313
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
438,254
444,174
477,445
576,409
596,734
550,889
602,536
694,152
808,017
1,351,065
1,360,441
1,389,674
1,352,018
1,306,078
1,374,210
1,218,647
1,175,790
1,178,013
1,251,327
1,200,999
1,229,625
1,229,6251,200,9991,251,3271,178,0131,175,7901,218,6471,374,2101,306,0781,352,0181,389,6741,360,4411,351,065808,017694,152602,536550,889596,734576,409477,445444,174438,2540000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
156,553
191,044
230,456
170,419
200,864
248,404
309,536
344,989
421,840
1,013,728
631,138
881,036
554,385
895,023
436,777
587,910
382,809
766,735
658,452
712,668
760,441
760,441712,668658,452766,735382,809587,910436,777895,023554,385881,036631,1381,013,728421,840344,989309,536248,404200,864170,419230,456191,044156,5530000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,092
79,041
0
1,031
5,007
0
0
384,000
80,000
393,000
0
500,000
200,000
380,000
0
180,300
40,000
20,000
20,00040,000180,3000380,000200,000500,0000393,00080,000384,000005,0071,031079,04177,0920000000000000000000000000000000000000000000
       Net Receivables 
43,415
48,935
52,923
53,155
65,943
48,044
66,228
66,801
52,800
47,765
56,128
59,776
67,203
50,399
67,702
80,703
91,032
68,314
96,113
113,171
114,408
103,995
141,708
151,532
149,946
173,116
200,168
234,904
231,940
190,872
187,053
240,967
196,849
148,415
136,234
168,182
171,441
131,952
139,245
179,223
159,305
149,834
131,853
178,049
163,479
163,651
114,179
215,321
221,210
205,735
187,295
273,299
155,297
148,329
122,668
104,681
112,104
106,202
101,568
153,800
147,379
147,379153,800101,568106,202112,104104,681122,668148,329155,297273,299187,295205,735221,210215,321114,179163,651163,479178,049131,853149,834159,305179,223139,245131,952171,441168,182136,234148,415196,849240,967187,053190,872231,940234,904200,168173,116149,946151,532141,708103,995114,408113,17196,11368,31491,03280,70367,70250,39967,20359,77656,12847,76552,80066,80166,22848,04465,94353,15552,92348,93543,415
       Other Current Assets 
323
2,176
26,379
18,096
9,578
4,071
46,506
1,969
9,967
1,296
9,891
7,094
9,266
22,885
23,029
28,978
26,334
3,200
6,143
3,427
3,228
9,444
7,853
7,354
19,062
4,375
14,361
11,136
26,872
6,206
7,273
11,539
14,827
2,495
63,467
10,473
69,050
4,665
8,882
21,273
36,035
9,158
6,529
8,177
7,159
16,494
24,899
10,237
36,055
14,484
29,022
11,806
45,340
12,716
61,807
22,415
12,400
13,659
13,932
38,817
6,866
6,86638,81713,93213,65912,40022,41561,80712,71645,34011,80629,02214,48436,05510,23724,89916,4947,1598,1776,5299,15836,03521,2738,8824,66569,05010,47363,4672,49514,82711,5397,2736,20626,87211,13614,3614,37519,0627,3547,8539,4443,2283,4276,1433,20026,33428,97823,02922,8859,2667,0949,8911,2969,9671,96946,5064,0719,57818,09626,3792,176323
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
851,016
757,736
792,433
1,072,929
1,329,575
1,358,782
1,399,154
1,496,508
1,509,074
1,517,823
1,554,655
1,596,804
1,593,629
1,743,979
1,640,120
1,637,501
1,626,388
1,632,822
1,641,427
1,641,4271,632,8221,626,3881,637,5011,640,1201,743,9791,593,6291,596,8041,554,6551,517,8231,509,0741,496,5081,399,1541,358,7821,329,5751,072,929792,433757,736851,016000000000000000000000000000000000000000000
       Property Plant Equipment 
40,988
38,171
36,165
37,740
34,961
37,447
37,569
85,703
82,971
62,879
60,741
62,528
62,686
77,003
76,810
112,448
113,148
142,332
140,858
166,521
158,506
160,814
160,198
161,163
170,629
196,698
200,517
206,616
216,506
238,538
245,886
253,867
240,486
255,866
258,214
266,066
273,989
283,250
290,477
300,994
310,331
331,943
336,282
358,094
356,200
353,261
596,340
624,391
650,212
739,477
742,456
743,000
785,681
793,919
790,923
807,971
814,557
840,459
829,667
853,802
862,680
862,680853,802829,667840,459814,557807,971790,923793,919785,681743,000742,456739,477650,212624,391596,340353,261356,200358,094336,282331,943310,331300,994290,477283,250273,989266,066258,214255,866240,486253,867245,886238,538216,506206,616200,517196,698170,629161,163160,198160,814158,506166,521140,858142,332113,148112,44876,81077,00362,68662,52860,74162,87982,97185,70337,56937,44734,96137,74036,16538,17140,988
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194,678
194,678
194,678
194,678
134,418
134,418
134,418
0
0
0
0
0
0
0
0
0
0
0
0
0
0
59,413
51,226
51,226
51,226
51,226
51,226
51,226
51,226
51,226
51,226
51,226
31,822
31,822
31,822
31,822
31,82231,82231,82231,82251,22651,22651,22651,22651,22651,22651,22651,22651,22651,22659,41300000000000000134,418134,418134,418194,678194,678194,678194,6780000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
435,766
452,543
454,680
336,165
367,270
645,692
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000645,692367,270336,165454,680452,543435,7660000000000000000000000000000000000000000
       Intangible Assets 
6,194
5,536
4,564
1,810
3,835
1,821
3,956
1,728
4,849
1,585
4,562
1,477
4,312
1,531
7,001
1,524
8,117
1,405
11,286
2,759
14,562
3,296
4,976
4,833
4,636
219,634
221,009
222,230
221,432
169,855
168,984
168,119
16,250
15,930
15,611
16,370
16,032
17,974
17,587
17,284
19,689
19,306
51,425
42,748
58,678
57,714
168,880
168,769
168,434
167,066
165,141
162,665
162,797
160,392
157,166
153,902
150,363
147,262
143,823
119,013
115,301
115,301119,013143,823147,262150,363153,902157,166160,392162,797162,665165,141167,066168,434168,769168,88057,71458,67842,74851,42519,30619,68917,28417,58717,97416,03216,37015,61115,93016,250168,119168,984169,855221,432222,230221,009219,6344,6364,8334,9763,29614,5622,75911,2861,4058,1171,5247,0011,5314,3121,4774,5621,5854,8491,7283,9561,8213,8351,8104,5645,5366,194
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,853
4,852
4,885
3,499
5,112
3,440
661,681
751,580
16,080
19,448
5,840
8,917
7,774
132,836
11,041
5,830
5,590
4,965
4,708
4,7084,9655,5905,83011,041132,8367,7748,9175,84019,44816,080751,580661,6813,4405,1123,4994,8854,8522,853000000000000000000000000000000000000000000
> Total Liabilities 
54,100
47,738
26,518
24,211
29,966
17,604
27,863
24,758
9,121
7,488
10,596
14,907
14,168
33,186
29,870
30,758
32,786
59,637
56,966
55,177
59,524
61,161
55,731
54,781
56,677
240,672
242,444
235,339
248,958
117,388
134,522
82,869
62,465
54,398
85,969
89,159
79,105
71,650
71,896
72,299
78,078
82,928
82,104
116,640
116,531
173,311
274,238
374,950
459,894
955,500
931,351
933,954
916,285
818,224
847,711
876,991
845,103
892,274
943,745
939,383
985,578
985,578939,383943,745892,274845,103876,991847,711818,224916,285933,954931,351955,500459,894374,950274,238173,311116,531116,64082,10482,92878,07872,29971,89671,65079,10589,15985,96954,39862,46582,869134,522117,388248,958235,339242,444240,67256,67754,78155,73161,16159,52455,17756,96659,63732,78630,75829,87033,18614,16814,90710,5967,4889,12124,75827,86317,60429,96624,21126,51847,73854,100
   > Total Current Liabilities 
52,400
46,038
26,519
24,211
29,966
17,604
27,863
24,758
9,121
7,488
10,596
13,407
12,793
18,951
15,635
16,523
18,584
26,435
23,813
22,074
26,630
28,792
23,888
23,464
26,192
185,703
186,961
180,993
194,240
78,148
96,704
45,973
38,637
29,402
61,856
64,628
54,472
49,224
49,778
49,626
56,349
62,143
62,264
96,610
97,446
125,890
137,149
237,734
323,005
343,542
311,838
325,470
299,421
285,558
305,661
311,487
274,914
302,669
289,596
283,270
327,245
327,245283,270289,596302,669274,914311,487305,661285,558299,421325,470311,838343,542323,005237,734137,149125,89097,44696,61062,26462,14356,34949,62649,77849,22454,47264,62861,85629,40238,63745,97396,70478,148194,240180,993186,961185,70326,19223,46423,88828,79226,63022,07423,81326,43518,58416,52315,63518,95112,79313,40710,5967,4889,12124,75827,86317,60429,96624,21126,51946,03852,400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,010
94,608
153,148
143,905
143,820
104,053
87,264
79,081
135,665
125,877
104,807
107,612
103,043
85,017
160,177
160,17785,017103,043107,612104,807125,877135,66579,08187,264104,053143,820143,905153,14894,6085,0100000000000000000000000000000000000000000000000
       Accounts payable 
25,550
19,510
19,438
13,276
20,817
14,224
22,365
18,358
3,073
2,136
1,734
2,221
1,872
1,705
2,442
3,738
5,533
8,954
5,605
6,324
7,606
6,910
4,421
4,102
5,850
13,941
14,207
14,768
16,115
10,603
24,110
15,968
10,234
11,225
35,856
39,173
23,433
12,079
17,053
7,973
18,282
21,514
31,206
66,336
58,596
55,295
82,679
70,774
101,096
137,027
103,814
150,597
156,315
141,127
111,537
130,892
108,424
140,903
126,705
133,340
105,130
105,130133,340126,705140,903108,424130,892111,537141,127156,315150,597103,814137,027101,09670,77482,67955,29558,59666,33631,20621,51418,2827,97317,05312,07923,43339,17335,85611,22510,23415,96824,11010,60316,11514,76814,20713,9415,8504,1024,4216,9107,6066,3245,6058,9545,5333,7382,4421,7051,8722,2211,7342,1363,07318,35822,36514,22420,81713,27619,43819,51025,550
       Other Current Liabilities 
8,850
6,528
2,081
5,935
4,149
3,380
5,498
6,400
6,048
5,352
8,862
11,186
10,921
17,246
13,193
12,785
13,051
17,481
18,208
15,750
19,024
21,882
19,467
19,363
20,343
111,707
112,698
106,170
103,450
35,646
40,695
30,004
28,403
18,177
26,000
25,454
31,040
37,145
32,724
41,652
27,957
13,014
22,794
14,129
29,914
40,979
44,525
51,869
66,407
32,483
50,692
27,342
22,728
18,892
29,719
13,349
24,859
259
3,179
16,582
111
11116,5823,17925924,85913,34929,71918,89222,72827,34250,69232,48366,40751,86944,52540,97929,91414,12922,79413,01427,95741,65232,72437,14531,04025,45426,00018,17728,40330,00440,69535,646103,450106,170112,698111,70720,34319,36319,46721,88219,02415,75018,20817,48113,05112,78513,19317,24610,92111,1868,8625,3526,0486,4005,4983,3804,1495,9352,0816,5288,850
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,840
20,030
19,086
47,421
137,090
137,216
136,888
611,958
619,514
608,484
616,864
532,666
542,050
565,504
570,189
589,605
654,149
656,113
658,332
658,332656,113654,149589,605570,189565,504542,050532,666616,864608,484619,514611,958136,888137,216137,09047,42119,08620,03019,840000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
397
136
138
14,982
10,651
9,982
9,314
8,614
7,896
7,8968,6149,3149,98210,65114,9821381363970000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,000
77,108
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000077,10877,0000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,485
31,050
33,057
34,421
38,731
46,626
30,133
32,044
34,311
36,166
41,631
42,244
43,738
32,403
32,661
34,532
35,078
0
0
15,709
0
015,7090035,07834,53232,66132,40343,73842,24441,63136,16634,31132,04430,13346,62638,73134,42133,05731,05027,4850000000000000000000000000000000000000000
> Total Stockholder Equity
71,731
94,408
132,938
143,925
153,642
433,678
443,695
447,454
458,936
467,625
476,234
466,841
479,466
491,470
502,412
491,134
507,548
523,959
537,545
526,154
542,255
559,381
598,786
596,009
618,127
623,201
644,557
670,813
694,621
891,163
911,677
940,096
965,285
901,695
914,840
958,902
1,017,374
1,069,235
1,097,990
1,141,361
1,183,004
1,205,791
1,246,357
1,217,505
1,272,636
1,450,507
1,479,070
1,513,659
1,586,107
1,741,905
1,793,107
1,830,560
1,847,888
1,856,488
1,896,445
1,863,031
1,819,546
1,776,340
1,789,194
1,751,886
1,744,333
1,744,3331,751,8861,789,1941,776,3401,819,5461,863,0311,896,4451,856,4881,847,8881,830,5601,793,1071,741,9051,586,1071,513,6591,479,0701,450,5071,272,6361,217,5051,246,3571,205,7911,183,0041,141,3611,097,9901,069,2351,017,374958,902914,840901,695965,285940,096911,677891,163694,621670,813644,557623,201618,127596,009598,786559,381542,255526,154537,545523,959507,548491,134502,412491,470479,466466,841476,234467,625458,936447,454443,695433,678153,642143,925132,93894,40871,731
   Common Stock
38,388
38,388
50,888
50,888
50,888
67,888
67,888
101,833
101,833
101,833
101,833
152,749
152,749
152,749
152,749
152,749
152,749
152,749
152,749
305,498
305,498
305,498
311,274
311,274
311,274
311,274
311,274
311,130
311,130
330,510
330,510
325,993
325,993
325,993
325,993
325,993
325,993
325,993
325,993
325,993
488,990
488,990
488,990
488,990
488,990
494,690
494,690
494,554
494,554
494,494
494,494
492,802
492,857
492,718
492,718
492,719
491,956
0
0
491,934
0
0491,93400491,956492,719492,718492,718492,857492,802494,494494,494494,554494,554494,690494,690488,990488,990488,990488,990488,990325,993325,993325,993325,993325,993325,993325,993325,993325,993330,510330,510311,130311,130311,274311,274311,274311,274311,274305,498305,498305,498152,749152,749152,749152,749152,749152,749152,749152,749101,833101,833101,833101,83367,88867,88850,88850,88850,88838,38838,388
   Retained Earnings 
23,389
43,336
12,301
23,195
32,913
37,613
47,630
51,389
62,871
67,344
75,953
66,560
79,185
86,717
97,659
86,381
102,795
112,862
126,448
115,057
131,158
141,758
193,844
188,361
207,772
233,644
254,074
270,510
293,429
248,285
268,799
298,460
323,649
258,144
281,302
326,845
358,416
373,701
402,456
446,331
487,973
509,402
473,500
497,373
552,505
805,871
831,251
862,816
931,757
945,958
996,410
1,032,988
1,046,253
1,041,520
1,080,783
1,047,086
1,062,417
871,149
883,730
994,145
838,721
838,721994,145883,730871,1491,062,4171,047,0861,080,7831,041,5201,046,2531,032,988996,410945,958931,757862,816831,251805,871552,505497,373473,500509,402487,973446,331402,456373,701358,416326,845281,302258,144323,649298,460268,799248,285293,429270,510254,074233,644207,772188,361193,844141,758131,158115,057126,448112,862102,79586,38197,65986,71779,18566,56075,95367,34462,87151,38947,63037,61332,91323,19512,30143,33623,389
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000-16,304-16,304-16,304-16,304-20,850-20,8500000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,661
-1,661
-1,686
-1,709
130,932
130,920
130,840
130,694
130,040
130,280
130,075
130,206
0
0
130,592
0
0130,59200130,206130,075130,280130,040130,694130,840130,920130,932-1,709-1,686-1,661-1,661000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue858,393
Cost of Revenue-444,212
Gross Profit414,181414,181
 
Operating Income (+$)
Gross Profit414,181
Operating Expense-861,801
Operating Income-3,409-447,621
 
Operating Expense (+$)
Research Development120,773
Selling General Administrative226,235
Selling And Marketing Expenses-
Operating Expense861,801347,007
 
Net Interest Income (+$)
Interest Income7,821
Interest Expense-52,148
Other Finance Cost-6,027
Net Interest Income-50,354
 
Pretax Income (+$)
Operating Income-3,409
Net Interest Income-50,354
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-64,578-3,409
EBIT - interestExpense = -52,148
-42,064
10,084
Interest Expense52,148
Earnings Before Interest and Taxes (EBIT)--12,430
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-64,578
Tax Provision--13,592
Net Income From Continuing Ops-50,986-50,986
Net Income-42,064
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-50,354
 

Technical Analysis of Beilu
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Beilu. The general trend of Beilu is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Beilu's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beijing Beilu Pharmaceutical.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.86 < 6.25 < 6.54.

The bearish price targets are: 4.08 > 3.58.

Tweet this
Beijing Beilu Pharmaceutical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beijing Beilu Pharmaceutical. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beijing Beilu Pharmaceutical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beijing Beilu Pharmaceutical. The current macd is -0.09252127.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Beilu price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Beilu. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Beilu price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Beijing Beilu Pharmaceutical Daily Moving Average Convergence/Divergence (MACD) ChartBeijing Beilu Pharmaceutical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beijing Beilu Pharmaceutical. The current adx is 18.06.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Beilu shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Beijing Beilu Pharmaceutical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beijing Beilu Pharmaceutical. The current sar is 4.13747072.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Beijing Beilu Pharmaceutical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beijing Beilu Pharmaceutical. The current rsi is 53.93. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Beijing Beilu Pharmaceutical Daily Relative Strength Index (RSI) ChartBeijing Beilu Pharmaceutical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beijing Beilu Pharmaceutical. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Beilu price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Beijing Beilu Pharmaceutical Daily Stochastic Oscillator ChartBeijing Beilu Pharmaceutical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beijing Beilu Pharmaceutical. The current cci is 40.41.

Beijing Beilu Pharmaceutical Daily Commodity Channel Index (CCI) ChartBeijing Beilu Pharmaceutical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beijing Beilu Pharmaceutical. The current cmo is 20.59.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Beijing Beilu Pharmaceutical Daily Chande Momentum Oscillator (CMO) ChartBeijing Beilu Pharmaceutical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beijing Beilu Pharmaceutical. The current willr is -10.41666667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Beijing Beilu Pharmaceutical Daily Williams %R ChartBeijing Beilu Pharmaceutical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beijing Beilu Pharmaceutical.

Beijing Beilu Pharmaceutical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beijing Beilu Pharmaceutical. The current atr is 0.23621615.

Beijing Beilu Pharmaceutical Daily Average True Range (ATR) ChartBeijing Beilu Pharmaceutical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beijing Beilu Pharmaceutical. The current obv is 127,320,508.

Beijing Beilu Pharmaceutical Daily On-Balance Volume (OBV) ChartBeijing Beilu Pharmaceutical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beijing Beilu Pharmaceutical. The current mfi is 54.05.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Beijing Beilu Pharmaceutical Daily Money Flow Index (MFI) ChartBeijing Beilu Pharmaceutical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beijing Beilu Pharmaceutical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Beijing Beilu Pharmaceutical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beijing Beilu Pharmaceutical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.927
Ma 20Greater thanMa 504.742
Ma 50Greater thanMa 1004.895
Ma 100Greater thanMa 2005.749
OpenGreater thanClose4.890
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Beilu with someone you think should read this too:
  • Are you bullish or bearish on Beilu? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Beilu? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beijing Beilu Pharmaceutical

I send you an email if I find something interesting about Beijing Beilu Pharmaceutical.


Comments

How you think about this?

Leave a comment

Stay informed about Beijing Beilu Pharmaceutical.

Receive notifications about Beijing Beilu Pharmaceutical in your mailbox!